Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: Anidulafungin Versus Fluconazole in the Treatment of Candidemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing anidulafungin to fluconazole for candidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anidulafungin (anidulafungin)
  • Fluconazole (Fluconazole)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Candida, Candidiasis | Phase 3 | Status: COMPLETED